Form 8-K - Current report:
SEC Accession No. 0001437749-12-002665
Filing Date
2012-03-22
Accepted
2012-03-22 16:06:08
Documents
10
Period of Report
2012-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K geovax_8k-031612.htm 8-K 41558
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 137767
3 EXHIBIT 4.1 ex4-1.htm EX-4.1 16215
4 EXHIBIT 10.1 ex10-1.htm EX-10.1 281424
5 EXHIBIT 10.2 ex10-2.htm EX-10.2 177866
6 EXHIBIT 10.3 ex10-3.htm EX-10.3 117024
7 EXHIBIT 10.4 ex10-4.htm EX-10.4 115655
8 EXHIBIT 10.5 ex10-5.htm EX-10.5 119233
9 EXHIBIT 99.1 ex99-1.htm EX-99.1 13633
10 image.jpg GRAPHIC 16646
  Complete submission text file 0001437749-12-002665.txt   1045014
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52091 | Film No.: 12709380
SIC: 8731 Services-Commercial Physical & Biological Research